I Stopped Plaquenil: Will My Retina Keep Getting Worse?
Stopping Plaquenil: What It Means for Your Retina
Did an eye doctor find early Plaquenil changes in your retina? If you have stopped the drug, the most likely path is a good one. When Plaquenil damage is caught early, before it is severe, there is usually only mild, limited change for about a year after you stop, and the odds of keeping good reading vision are high.1 The picture is harder when damage is already advanced. That is why your stage matters more than the fact that you stopped.
There is no pill or drop that reverses established damage, so removing the cause is the main treatment. Hydroxychloroquine treats conditions such as lupus and rheumatoid arthritis and can rarely cause serious, sometimes irreversible eye problems, which is why regular eye exams are advised while you take it.2 Stopping does not undo changes that are already there, but it removes what was driving them, and for early cases that is usually enough to protect your vision.
This page explains what 'Plaquenil retina damage' actually means, how to tell early changes from advanced ones, why a small number of people keep progressing after stopping, and exactly when to call your eye doctor. It does not replace your own eye doctor's read of your scans, which is the only way to know your personal stage and plan.
Is Plaquenil Retina Damage an Eye Emergency?
Plaquenil retinal toxicity develops and changes slowly, over months and years, not overnight. It is not the kind of problem that sends you to the emergency room, and there is no same-day treatment that changes its course once you have stopped the drug. The right response is a scheduled visit with your eye doctor for imaging, not a rush to the ER. Take a breath: for early, recently stopped cases, calm monitoring is the plan.
Plaquenil damage is slow, so a sudden change is usually something else and deserves a prompt call the same day. Contact an eye doctor or urgent eye service right away if you notice any of these, which are not typical of hydroxychloroquine toxicity:
- A sudden shower of new floaters, or new flashes of light.
- A dark curtain, shadow, or veil moving across part of your vision.
- Sudden loss of vision in one eye, painless or painful.
- New, rapid distortion where straight lines look bent or a spot goes dark quickly.
These can signal a retinal tear, detachment, or other acute problem that is treatable when caught early, so acting the same day protects your sight.
What Plaquenil Retinal Toxicity Actually Is
Hydroxychloroquine toxicity affects the light-sensing photoreceptors and the retinal pigment cells near the center of the macula, the tissue you use for sharp central and reading vision.3 Because these cells do not regenerate once they are lost, the goal of care is to catch trouble while changes are still subtle and stop the drug before the damage becomes fixed.
Screening now relies on sensitive macular OCT and wide-pattern autofluorescence imaging to catch hydroxychloroquine changes early, well before an advanced 'bull's-eye' pattern of pigment change would appear.1 That bull's-eye, a ring of pigment change that often spares the very center of vision until late, is a late sign, and the goal of modern screening is to act long before it shows up.
The same imaging that finds toxicity is used to follow it. Even after you stop the drug, your eye doctor may keep repeating retinal images to see whether the changes are holding steady or slowly advancing, especially if the damage was more than early.4
Signs and Symptoms to Recognize
In its early stages hydroxychloroquine toxicity usually causes no symptoms and is found only on imaging, which is exactly why regular screening exists.1 If your damage was picked up on a scan while your vision felt normal, that is the system working as intended, catching it before you could notice.
As toxicity progresses, some people notice a small blind spot or gray patch just off the center of vision, missing letters when reading, or trouble seeing in dim light.3 These changes tend to be gradual. A symptom that appears suddenly points to a different, more urgent problem, not to slow Plaquenil toxicity.
Between visits, checking each eye separately on something with straight lines, such as a doorframe or an Amsler grid your doctor can provide, helps you notice a new blank spot or distortion. Report any change to your eye doctor rather than waiting for your next scheduled scan.
Why Damage Can Keep Going After You Stop
Whether Plaquenil retinal toxicity keeps progressing after the drug is stopped depends mainly on how advanced the damage already was at the time you stopped.4 Early, thin changes tend to settle; more established damage has more momentum. This is the single most useful thing to ask your eye doctor about your own scans.
Hydroxychloroquine builds up slowly in the eye's tissues over years of use, which is why toxicity is a long-term risk rather than a sudden one, and why some effects continue for a while after the last dose. The photoreceptor and retinal pigment cells that hydroxychloroquine injures do not regenerate, so changes already present can continue to evolve, and the retinopathy tends to progress even after the drug is stopped.3
The main risk factors for hydroxychloroquine toxicity are a higher daily dose for your body weight, many years of use, kidney disease, which roughly doubles the risk, taking tamoxifen at the same time, and starting the drug at an older age.1 These help explain why some long-term users develop changes while many others never do.
Will It Keep Getting Worse? Your Realistic Outlook
For most people found through screening, the news is good. When hydroxychloroquine retinopathy is recognized before extensive damage, stopping the drug typically leads to only mild, limited progression for about a year and a low risk of meaningful vision loss, whereas advanced retinopathy can continue to progress even after stopping and is not reversible to any significant degree; at the recommended weight-based dose, below about 5 milligrams per kilogram each day, the chance of toxicity stays under about 1 in 100 over the first five years and under about 2 in 100 even after ten years of use.1
Being honest matters here, especially if your damage was more than early. Because advanced toxicity tends to progress even after the drug is stopped, ongoing imaging is used to follow the changes over time rather than to reverse them.3 Even so, many people keep functional central vision for a long time, which is why continued follow-up is worth it.
Progression, when it happens, is typically slow and measured in scan changes over months to years, not sudden loss. That is why the plan is scheduled imaging and, if needed, low-vision support, rather than urgent intervention. Your eye doctor can tell you which pattern your scans fit and roughly how closely you should be watched.
When to Call Your Eye Doctor, and Who to See
Stopping the drug is not the end of eye care. Because established changes can continue to evolve, doctors keep imaging the retina after hydroxychloroquine is stopped to confirm whether the damage is stable or advancing.4 Ask your eye doctor how often you should be rechecked; for advanced damage this is usually more frequent than for early, stable changes.
Screening and monitoring for hydroxychloroquine toxicity are done by an eye doctor, an optometrist or ophthalmologist, using retinal imaging, and complex or advancing cases are often followed by a retina specialist. Decisions about hydroxychloroquine itself are made together with the doctor who prescribed it, often a rheumatologist, so that your eye findings and your underlying disease are weighed together.1 Keep both doctors in the loop.
Between visits, call your eye doctor if you notice a new or growing blind spot, new distortion, or any drop in your reading vision. Call the same day for the sudden warning signs listed earlier, since those point to a different, time-sensitive problem rather than slow Plaquenil toxicity.
Common Questions After Stopping Plaquenil
Hydroxychloroquine collects in the eye's tissues over years, and the cells it injures, the photoreceptors and pigment cells, do not regenerate. So while stopping removes the cause, whether damage keeps advancing depends mostly on how far it had progressed when you stopped.4 Early changes usually settle within about a year, while advanced damage can keep evolving slowly. Your scans, not the calendar, tell your doctor which path you are on.
Usually not fully. Hydroxychloroquine can cause serious and sometimes irreversible eye changes, so damage that is already established generally does not fully recover after stopping.2 A small number of very early cases have shown slight improvement, but that is the exception. The realistic goal is to preserve the vision you have and prevent further loss. Many people keep useful central and reading vision for years, especially when the problem was caught early through screening.
Your eye doctor compares repeat images over time, mainly OCT scans and fundus autofluorescence, to see whether the changes are stable or advancing.3 This is why keeping your baseline and follow-up scans in one place matters. Small, slow changes on imaging are the expected way progression shows up, long before you would notice it yourself.
No. Most long-term users never develop toxicity. At recommended dosing the risk stays under about 1 in 100 over five years and under about 2 in 100 even after ten years, rising mainly with higher weight-based dose, longer use, kidney disease, and tamoxifen.1 Screening exists precisely to find the small number who do develop changes early, when stopping the drug still protects vision.
That is a shared decision, not one this page can make. Hydroxychloroquine is widely used to control conditions such as lupus and rheumatoid arthritis, and the rare risk of eye toxicity is weighed against how much the drug helps your disease. Your prescriber and eye doctor balance retinal findings against how well the drug controls your condition and what alternatives exist, so ask them to walk through that trade-off with you.
That decision belongs to your prescriber and eye doctor together, based on how much toxicity you have and how much you need the drug. Once retinal toxicity is confirmed, hydroxychloroquine is usually not restarted, because further exposure can add to damage that is already irreversible. If your underlying disease flares, your rheumatologist can discuss alternative medications rather than resuming a drug your retina has reacted to.
More Questions People Ask
No, and that is the point of modern screening. A visible bull's-eye is a late, advanced sign, so screening now uses sensitive OCT and autofluorescence imaging to catch changes well before that stage.3 If your damage was found before a bull's-eye appeared, it was caught relatively early, which is exactly what improves the odds of stable vision after you stop the drug.
Either can screen and monitor. Routine screening and imaging are done by an optometrist or ophthalmologist, and many stable, early cases stay with that doctor. More advanced or clearly progressing damage is often referred to a retina specialist for closer follow-up. Whichever eye doctor you see coordinates with the prescriber who manages your hydroxychloroquine, so decisions about the drug and your eyes are made together.1
There is no single number that fits everyone. Because damage can keep advancing after stopping, doctors continue periodic imaging to track it, more often for advanced changes and less often for early, stable ones.4 Ask your eye doctor to set a specific interval for you and to tell you what change on your scans would prompt seeing you sooner. Do not assume that stopping the drug means you can stop being watched.
- Based on my scans, is my toxicity early or advanced, and what does that mean for progression?
- How often should I have OCT and autofluorescence imaging now that I have stopped?
- What specific change on my scans or vision would mean I should be seen sooner?
- Should a retina specialist be involved in my follow-up?
- How should my eye findings and my lupus or arthritis treatment be balanced going forward?
- American Academy of Ophthalmology (Clinical Statement) (2025). Recommendations on Screening for Hydroxychloroquine Retinopathy.
- MedlinePlus (U.S. National Library of Medicine) (2024). Hydroxychloroquine.
- Review of Ophthalmology (2019). Multimodal Imaging in Plaquenil Toxicity.
- Review of Optometry (2018). Is Damage Still Occurring? (Plaquenil).